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ABSTRACT
MicroRNAs (miRNAs) are small non-coding RNAs
that regulate expression by translational repression
or messenger RNA (mRNA) degradation. Although
numerous bioinformatic prediction models exist to
identify miRNA–mRNA interactions, experimental
validation of bona fide interactions can be difficult
and laborious. Few methods can comprehensively
identify miRNAs that target a single mRNA. We
have developed an experimental approach to
search for miRNAs targeting any mRNA using a
capture affinity assay involving a biotinylated DNA
anti-sense oligonucleotide. This method identifies
miRNAs targeting the full length of the mRNA.
The method was tested using three separate
mRNA targets: alpha-1 antitrypsin (AAT) mRNA,
interleukin-8 mRNA and secretory leucoprotease in-
hibitor mRNA. AAT mRNA-specific and total miRNAs
from three different cell lines (monocytic THP-1,
bronchial epithelial 16HBE14o and liver HepG2
cells) were profiled, and validation studies revealed
that AAT mRNA-specific miRNAs functionally target
the AAT mRNA in a cell-specific manner, providing
the first evidence of innate miRNAs selectively tar-
geting and modulating AAT mRNA expression.
Interleukin-8 and secretory leucoprotease inhibitor
mRNAs and their cognate miRNAs were also suc-
cessfully captured using this approach. This is a
simple and an efficient method to potentially
identify miRNAs targeting sequences within the full
length of a given mRNA transcript.
INTRODUCTION
MicroRNAs (miRNAs) are a class of small non-coding
RNAs that regulate messenger RNA (mRNA) at the
post-transcriptional level. These highly conserved 21-mer
RNAs regulate the translation of mRNA transcripts by
binding principally to the 30untranslated regions (30UTR)
of speciﬁc mRNAs. The primary transcripts of miRNAs,
called pri-miRNAs, are transcribed as polycistrons or
co-transcribed with protein-coding genes, being
embedded in introns or exons (1). The RNase Drosha
further processes the primary transcripts of miRNAs
into 70–100-nt hairpin-shaped pre-miRNAs, which are
exported from the nucleus by exportin 5 (2). After the
latter are cleaved to mature forms by Dicer, miRNAs
guide a complex of proteins that includes a member of
the Argonaute family (Ago), assemble into the
RNA-induced silencing complex (RISC) and negatively
regulate expression by either translational repression or
mRNA degradation (3).
Each miRNA is thought to regulate multiple tran-
scripts, and many transcripts are thought to be regulated
by multiple miRNAs. Target mRNA identiﬁcation is
challenging because miRNAs bind to their target
mRNAs by partial complementarity over a short
sequence. Nucleotides 2–8 of the miRNA, termed the
‘seed sequence’, are essential for target recognition and
binding (4). miRNA targets for individual mRNAs can
be predicted through a number of freely available bio-
informatic programs, which apply free-energy prediction
(G) thermodynamic calculations for miRNA binding
afﬁnities to sites within the full length of an mRNA or
more commonly within its 30UTR. Deﬁning bona ﬁde
targets of a miRNA is probably the most tedious aspect
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of miRNA research owing to high false-positive rates sec-
ondary to imperfect pairing and temporal/spatial differ-
ences of miRNA:mRNA interactions (5).
Experimental methods to identify miRNA targets
include reporter gene assays for 30UTR analysis and
transcriptome and proteome analysis following miRNA
modulation using pre-miRs or anti-miRs (6).
Biochemical assays to search for target mRNAs of a
known miRNA using pull-down approaches have been
described. These include the use of highly speciﬁc mono-
clonal antibodies (7), isolation of complementary DNA
(cDNA) clones of target mRNAs that base pair in vivo
with an endogenous miRNA (8) and tagged miRNAs
such as biotinylated (9) or digoxigenin-labelled miRNA
(10). Other puriﬁcation methods proven in vitro include
the tandem afﬁnity puriﬁcation of miRNA:mRNA
(TAP-Tar) in which complexes are sequentially
immunoprecipitated using anti-Ago antibodies and then
via the miRNA using streptavidin beads (11,12). The
high-throughput sequencing of RNA isolated by cross-
linking immunoprecipitation (HITS-CLIP) system also
explores miRNA–mRNA interaction sites in vitro
using antibodies against members of the Ago protein
family (13). Another method called photoactivatable-
ribonucleoside-enhanced cross-linking and immunopre-
cipitation (PAR-CLIP) was developed to uncover tens of
thousands of binding sites for several important RNA-
binding proteins (RBP) and can be used to assess the regu-
latory impact of miRNA binding on their targets (14).
Unexpectedly, besides 30UTR binding sites, these studies
revealed that a large proportion of miRNA targets were
mapped within the mRNA coding region.
Recently, methods to comprehensively identify
miRNAs that regulate a single mRNA of interest have
been developed. One method uses luciferase 30UTR
reporter genes in which individual miRNAs must be trans-
fected into a cell line (15). However, this approach can be
laborious especially when bioinformatic screening predicts
multiple potential regulatory miRNAs. An afﬁnity puriﬁ-
cation approach involving fusion of the 30UTR of the
mRNA of interest with an MS2 tag cloned downstream
of a green ﬂuorescent protein (GFP) reporter has also
been developed whereby mRNA:miRNA complexes are
captured with an MS2-binding protein (16). As both of
these techniques are limited to the 30UTR, miRNAs tar-
geting the 50UTR or coding region will not be identiﬁed.
Here, we have developed an experimental approach to
search for target miRNAs of a known, speciﬁc mRNA.
Using formaldehyde to stabilize ternary complexes
between endogenous miRNA, mRNA and RBPs, we de-
veloped an afﬁnity assay for isolation of a speciﬁc mRNA
with its bound miRNAs using a biotinylated DNA
anti-sense capture oligonucleotide speciﬁc to the mRNA
of interest. We ﬁrst selected the alpha-1 antitrypsin (AAT)
mRNA for this study owing to the differential regulation
and expression of AAT in different cell types. AAT is a
serine proteinase inhibitor mainly produced by hepato-
cytes but has also been shown to be synthesized by mono-
cytes and bronchial epithelial cells. In AAT deﬁciency
(also known as genetic emphysema), endoplasmic reticu-
lum stress can occur owing to the aberrant folding of the
mutant Z protein in these cell types (17–19). There are 11
transcript variants of the AAT mRNA all over 3000 nu-
cleotide bases and each of which encodes the same protein.
Using the method described herein, miRNAs targeting the
AAT mRNA were successfully isolated and proﬁled.
Validation studies were performed using miRNA
Taqman assays, quantitative reverse transcriptase-
polymerase chain reaction (qRT-PCR) and enzyme-linked
immunosorbent assay (ELISA) after miRNA modulation.
The data generated show bona ﬁde miRNAs targeting the
AAT mRNA that are speciﬁc to three different cell types.
To demonstrate the general applicability of this method,
we also developed strategies to successfully capture
interleukin-8 (IL-8) and secretory leucoprotease inhibitor
(SLPI) mRNA:miRNA complexes from monocytic cells.
This approach is a simple and efﬁcient method to poten-
tially identify miRNAs targeting anywhere within the full
length of an mRNA transcript.
MATERIALS AND METHODS
Cell culture and treatments
All cell lines were maintained at 37C in a humidiﬁed CO2
incubator in appropriate media. THP-1 (human acute
monocytic leukemia cell line), HepG2 (human
hepatocellular carcinoma cell line) and HEK293 (human
embryonic kidney cell line) cells were obtained from the
European Collection of Cell Cultures (Salisbury, U.K).
16HBE14o cells (human bronchial epithelial cell line)
were obtained as a gift from D. Gruenert (California
Paciﬁc Medical Center Research Institute, San Francisco,
CA). THP-1 and HepG2 cells were cultured in RPMI 1640
and Dulbecco’s modiﬁed Eagle’s medium (Sigma-Aldrich,
St. Louis, MO), respectively, whereas both 16HBE14o
and HEK293 cells were cultured in Minimal Essential
Medium (Sigma-Aldrich). All culture media contained
10% fetal calf serum (Gibco, Billings, MT) and 1% peni-
cillin/streptomycin (Invitrogen, Carlsbad, CA) with the ex-
ception of that for HepG2 cells, which was supplemented
with L-glutamine and 0.1mM non-essential amino acids.
Before treatment, cells were washed with serum free media.
For IL-8 mRNA:miRNAs capture, THP-1 cells were
stimulated with lipopolysaccharide (LPS) (Sigma-Aldrich,
20 mg/ml for 6 h).
Quantitative assessment of mRNA and miRNA levels
RNA was isolated using TRI reagent (Sigma-Aldrich) ac-
cording to the manufacturer’s instructions. For quantiﬁ-
cation of mRNA, equal quantities of RNA calculated
using a Nanodrop were reverse transcribed into cDNA
using the Quantitect Reverse Transcription kit (Qiagen,
Valencia, CA). The resulting cDNA was used as
template for quantitative real-time PCR. Oligonucleotide
primers were synthesized (MWG, Biotech, Ebersberg) and
quantitative PCR reactions performed in 20 ml containing
2 ml of template cDNA, SYBR Green MasterMix (Roche,
Basel, Switzerland) and 10 pmol of each primer
(Supplementary Table S1) for AAT, glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), b-actin, IL-8,
SLPI and insulin-like growth factor 1 (IGF-1). Besides
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GADPH and b-actin, which are reference mRNAs and are
expressed in high abundance, IL-8 and IGF-1 mRNAs are
also expressed in all cell lines (Supplementary Figure
S1A). miRNA expression was measured using Taqman
miRNA assays (Applied Biosystems, Austin, TX) accord-
ing to the manufacturer’s instructions. Ampliﬁcation for
both mRNA and miRNA was performed on the Roche
LC480 Lightcycler in triplicate samples, including
no-template controls. Relative expression of transcripts
and miRNAs relative to GAPDH and miR-16, respect-
ively, were determined using the 2Ct method (20).
GAPDH mRNA and miR-16 were chosen to normalize
mRNA and miRNA, respectively. miR-16 is not predicted
to regulate any of the mRNAs involved in this study; its
expression is similar across all three cells and was un-
affected by modulation studies involving pre-miRs and
anti-miRs.
AAT ELISA
Supernatants were recovered from THP-1, 16HBE14o
and HepG2 cells. AAT protein concentrations in these
samples were determined by sandwich ELISA using
speciﬁc antibodies to AAT (ICN Biomedicals, Solon,
OH) (21).
Transfection of pre-miRs, anti-miRs and reporter plasmids
THP-1, 16HBE14o and HepG2 cells (1 105 in tripli-
cate) were left non-transfected or transiently transfected
(24 and 48 h) with indicated doses of a negative control
pre-miR, synthetic pre-miRs or anti-miRs (Ambion, Life
Technologies) using Ribojuice (Novogen, Madison, WI)
in OptiMEM-reduced serum media (Life Technologies,
Carlsbad, CA). The synthetic pre-miRs are small, chem-
ically modiﬁed double-stranded RNA molecules that act
as miRNA mimics, whereas the anti-miRs are chemically
modiﬁed, single-stranded nucleic acids designed to specif-
ically bind to and inhibit endogenous miRNA molecules.
RNA was isolated for qRT-PCR and Taqman miRNA
assays, whereas supernatants were recovered for ELISA.
HEK293 cells (1 105 in triplicate) were transiently
transfected with 250 ng pMIR-AAT-30UTR (Origene,
Rockville, MD) and 100 ng of the reference Renilla
luciferase reporter plasmid pRLSV40 (Promega,
Madison, WI) with Genejuice (Novagen). The pMIR
AAT vector is a 30UTR-luciferase reporter in which the
AAT 30UTR is cloned downstream of the ﬁreﬂy luciferase
gene. Lysates were prepared and assayed for both
ﬁreﬂy and Renilla luciferase using the Luciferase assay
system (Promega) and coelenterazine (Marker Gene
Technologies, Eugene, OR). Fireﬂy luciferase activity
was normalized to the Renilla luciferase activity.
mRNA:miRNA isolation technique
Biotinylated DNA oligonucleotide design
The secondary structures of the 11 mRNA transcript
variants of AAT were modelled with M-Fold
(mfold.rna.albany.edu/?q=mfold/RNA-Folding-Form).
Two of the most thermodynamically stringent structures
for each variant were selected, and an exposed
single-stranded region, which was present in all variants,
was identiﬁed between bases 2283 and 2304 of transcript
variant 1 (Figure 1). Analysis with Basic Local Alignment
Search Tool (BLAST, blast.ncbi.nlm.nih.gov/Blast.cgi)
showed the sequence to have 100% total coverage and
be exclusive to all but only transcripts of AAT mRNA.
An anti-sense DNA oligonucleotide capture sequence
(50-GATAGAGAAAACAAAGCAGAGA-30) with a 50
biotin modiﬁcation was designed based on the canonical
Watson–Crick RNA and DNA base paring. A mismatch
DNA oligonucleotide capture sequence (altered bases
indicated in bold) 50-GATAGAGAAAACAATAAAGA
GA-30 also with a 50-biotin modiﬁcation was designed as
a negative control capture probe. Additional
oligonucelotides to capture AAT mRNA included a
20-mer oligonucleotide (50-GGGGTTGCGGGGGTCAA
2. Call-out and sequence of exposed ss loop
3. DNA capture oligonucleotide 
Biotin 5’-GATAGAGAAAACAAAGCAGAGA-3’
1. M-Fold secondary structure of 
AAT mRNA transcript variant 
#1 with exposed ss loop (red) 5’
3’
5’-UCUCUGCUUUGUUUUCUCUAUC-3’
Figure 1. Design of AAT mRNA capture oligonucleotide. (1) Proposed secondary structure of AAT transcript variant 1 using M-fold, (2) an
exposed single-stranded region (ss) located between bases 2283 and 2304 of transcript variant 1 is present in all variants, (3) sequence of DNA
capture oligonucleotide.
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TGG-30) complementary to a second predicted
single-stranded loop at position 2454–2474 and a 22-mer
(50-CTGAAGACTGCAGGGACAGCAA-30) designed to
capture a predicted double-stranded region at position
2532–2554.
To test the method on SLPI and IL-8 mRNAs, (i) a
30-mer capture oligonucleotide (50 TTATTTATTCATT
GATCAACTGGCACTTCT-30) was designed to target a
predicted single-stranded loop at position 546–576 in
SLPI mRNA and (ii) as the IL-8 mRNA did not have
any predicted single-stranded loops >15 nucleotides, a
capture oligonucleotide (5-GTGGCCTCTGAAGATCT
GCAGGGACAGCAA -30) directed against a predicted
double-stranded region at position 413–443 was
designed. Mismatch capture oligonucleotides with three
mismatches were also designed for SLPI mRNA and
IL-8 mRNA.
Formaldehyde cross-linking and cell lysis
Cells (5 107 cells in triplicate) were treated with 37%
formaldehyde (Sigma-Aldrich) to a ﬁnal concentration
of 1% and incubated at room temperature for 15min
for cross-linking (22). Glycine was added to a ﬁnal con-
centration of 0.2M to stop the cross-linking process, and
cells were washed with ice-cold Tris-buffered saline. Cell
lysis was performed in lysis buffer (50mMHEPES pH 7.5,
140mM NaCl, 1mM EDTA, 1% Triton, 0.1 % sodium
deoxycholate) using a FastPrep cell disrupter 4–5 times at
speed 5.5 for 30 s. DNA removal was performed by adding
RNase-free DNase (Qiagen) and incubating at 37C for
15min. This reaction was stopped with a ﬁnal concentra-
tion of 20mM EDTA. Supernatants recovered following
12 000g centrifugation for 5min were used for
mRNA:miRNA capture. All buffers were treated with
100 protease inhibitor (Roche, Mannheim, Germany)
and RNase inhibitor (Promega).
Streptavidin bead preparation and miRNA:AAT mRNA
pulldown
Immobilization of 2000 pmol/ml of biotinylated capture
oligonucleotide with 10mg of streptavidin beads
(Dynabeads M-280 Streptavidin) was performed accord-
ing to the manufacturer’s instructions. Oligo-prepared
beads (10mg) were incubated with 1ml of binding buffer
[20 mM Tris–HCl (pH 7.5), 2mM EDTA, 1M LiCl] and
mixed with an equal volume of formaldehyde-treated cell
lysates for 30min at room temperature for adequate an-
nealing. The beads were washed twice using washing
buffer [10 mM Tris–HCl (pH 7.5), 1mM EDTA,
0.15mM LiCl] and AAT mRNA:miRNA complexes
were captured using a Dynal magnet. The beads were sus-
pended in 10mM Tris–HCl (pH 7.5) before heat treatment
at 80C for 5min to reverse the interaction between the
biotin-labelled DNA:mRNA:miRNA complexes and the
magnetic beads. Cross-linked nucleic acids and proteins
were treated with proteinase K (Sigma-Aldrich) for diges-
tion of RBPs and remaining DNase for 1 h at 42C. Next
incubation at 65C for 20min was performed to fully
reverse the cross-linkages. Validation was performed to
conﬁrm the presence of AAT mRNA and true target
miRNAs and to rule out the presence of other mRNAs
and miRNAs by qRT-PCR and Taqman miRNA assay.
To determine the enrichment of the mRNA of interest
compared with the expression of highly abundant
mRNAs that may non-speciﬁcally bind to the oligo-beads,
the 2Ct method was used to normalize the Cq values
against baseline expression of mRNAs in cell lysates.
Expression proﬁling of total and AAT mRNA-speciﬁc
miRNAs
Total miRNAs and AAT mRNA-speciﬁc miRNAs
isolated from THP-1, 16HBE14o and HepG2 cell lines
were proﬁled commercially with the nCounter miRNA
Expression Assay (Nanostring Technologies, Seattle
WA). The samples were prepared with the nCounter
miRNA Sample Preparation Kit according to manufac-
turer’s instructions. Raw data were normalized based on
the relative number of positive control counts and adjusted
for probe and background corrections for each miRNA as
available in the nCounter Data Analysis Guidelines.
Statistical analysis
All analyses were performed using GraphPad Prism 4.0
software package (San Diego, CA). Results are expressed
as the mean ±SEM and were compared by Student t-test
(non-parametric, one tailed; Mann–Whitney) or
one-sample t-test compared with 1.0 for data generated
by the 2Ct method, as appropriate. Differences were
considered signiﬁcant at P-values of 0.05.
RESULTS
Differential expression of AAT mRNA and protein
AAT is differentially expressed in hepatocytes, bronchial
epithelial cells and monocytes. Using HepG2, 16HBE14o
and THP-1 as representative cells lines for these cell types,
AAT mRNA and protein expression were quantiﬁed by
qRT-PCR and ELISA, respectively. AAT mRNA expres-
sion in cell lines showed highest expression in the
HepG2> 16HBE14o>THP-1 (Supplementary Figure
S2A). AAT is a secreted protein and cell supernatants con-
tained 17 231±1092, 148±15 and 18±2ng/ml of AAT,
respectively, (Supplementary Figure S2B).
AAT mRNA is a direct and functional target of miRNAs
Although transcriptional mechanisms contribute to
altered AAT expression in different cell types, cell-speciﬁc
miRNAs are also likely to play a role. To predict
which miRNAs can potentially target the 30 UTR of the
AAT mRNA, all 11 transcript variants of AAT were
analysed for putative miRNA-binding sites using
miRanda (www.microRNA.org), Targetscan (www.
targetscan.org), Microcosm (www.mirbase.org) and
PicTar (pictar.mdc-berlin.de). Together, these databases
predicted hundreds of miRNAs including miR-940 for
which there are four possible miRNA recognition
elements (MRE) in the 30UTR of the AAT mRNA; the
fourth is situated at 30 end of the UTR, a location more
predictive of a true target (4). This site also has a high
miR-SVR score of (0.51) (23). Two other miRNAs
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with high miR-SVR scores were miR-132 and miR-212
(Supplementary Figure S3A).
Using standard miRNA methodologies to determine
whether AAT mRNA is a molecular target of miR-940,
miR-132 and miR-212, the effect of pre-miRs on expres-
sion of a luciferase gene under the control of the AAT
30UTR (pMiR-REPORT-AAT) was examined in
HEK293 cells. This resulted in signiﬁcant decreases of
up to 50% in luciferase expression from the AAT
30UTR reporter vector compared with cells transfected
with a negative control pre-miR (Supplementary Figure
S3B), demonstrating a causal relationship between the
three miRs and the AAT 30UTR (P< 0.0001). Controls
performed with pre-miR-126 and pre-miR-145, which are
not predicted to regulate AAT mRNA, showed no
changes in luciferase gene expression (data not shown).
The effect of pre-miR overexpression on AAT mRNA
levels was next assessed. miR-940, miR-132 and miR-212
are not differentially expressed in THP-1, 16HBE14o or
HepG2 cells (Supplementary Figure S1B). Transfection
with pre-miR-940, -132 or -212 into these cells resulted
in signiﬁcant increases of over 1000-fold in the expression
of each speciﬁc miRNA in HepG2 cells compared with
non-transfected cells (Supplementary Figure S4A).
qRT-PCR of AAT mRNA showed signiﬁcantly reduced
expression of 80, 74 and 55% in the three cell lines, re-
spectively, following pre-miR-940 overexpression
(P 0.05, where ‘no pre-miR’ has been artiﬁcially set to
1.0) (Supplementary Figure S5). AAT ELISA on super-
natants showed reductions of 31–55% in AAT protein
production and secretion compared with non-transfected
cells or negative control pre-miR-transfected cells
(Supplementary Figure S5). There were no signiﬁcant
changes in AAT mRNA or protein production in
response to pre-miR-132 or pre-miR-212 transfection.
Only combined transfections with more than one pre-
miR that included pre-miR-940 showed a reduction of
both the AAT mRNA and protein (data not shown).
It was also assessed whether anti-miR-940, -132 and -
212 functionally increase AAT mRNA and protein pro-
duction. Only cells transfected with anti-miR-940 resulted
in signiﬁcant increases in AAT mRNA expression
(compared with ‘no pre-miR’, which was artiﬁcially set
to 1.0) and protein production with fold changes ranging
from 1.6 to 5.6–fold for mRNA and from 1.26 to 1.7–fold
for protein (Supplementary Figure S6). There were no
effects on the relative expression of miRNAs other than
the speciﬁc miRNA targeted by each anti-miR with 20%
inhibition evident using 30 nM anti-miR however higher
concentrations of anti-miR are likely to lead to improved
knockdown (Supplementary Figure S4B). Together, these
data establish that AAT mRNA can be modulated by
miR-940 and that although miR-132 and mR-212 are pre-
dicted to target the 30UTR of AAT mRNA, modulation of
these miRs does not signiﬁcantly affect AAT mRNA or
protein expression.
AAT mRNA-speciﬁc isolation technique
To study miRNA regulation of AAT mRNA in more
detail, an afﬁnity capture technique was designed to
capture the AAT mRNA with its cognate miRNAs
bound in a format amenable to downstream qualitative
and quantitative study. First, the proposed secondary
structures of all 11 AAT transcript variants were
modelled using the M-fold web server. A predicted
single-stranded region located between bases 2283 and
2304 of transcript variant 1, which is present in all
variants, was used as a target against which a 50
biotinylated DNA capture oligonucleotide was designed
(Figure 1). Cells were treated with formaldehyde to
cross-link miR-Ago-RISC complexes with mRNA, lysed
and treated with RNase-free DNase, and the biotinylated
DNA capture oligonucleotide was used to capture AAT
mRNA:miRNA complexes with streptavidin-coated
magnetic beads. Samples were eluted from the magnetic
beads, the DNase was inactivated and the formaldehyde
cross-links were reversed. The resulting samples were used
for qRT-PCR, miRNA TaqMan assays and miRNA ex-
pression proﬁling (Figure 2).
Validation of AAT mRNA:miRNA isolation technique
To validate the AAT mRNA:miRNA complex afﬁnity
puriﬁcation method, qRT-PCR was performed with
AAT, GAPDH, b-actin, IL-8 and IGF-1 primers. Levels
of mRNA in the ‘captured’ sample were normalized
against levels of the same mRNA in cell lysates that did
not undergo the capture procedure to identify the back-
ground noise caused by highly abundant mRNAs that
might associate with the streptavidin-coated beads
non-speciﬁcally. This was performed using the 2Ct
method. There was a substantial enrichment of the AAT
mRNA by 16–75-fold compared with other highly
abundant mRNAs in all three cell lines. The data for
HepG2 cells are shown in Figure 3A. qRT-PCR was
also performed on the remaining cell lysates post-capture,
which showed that non-AAT mRNAs were not captured
compared with the AAT mRNA (Figure 3B, where AAT
mRNA levels in captured samples were artiﬁcially set to
1.0).
To conﬁrm that the 5-min heat treatment at 80C used
to reverse the interaction between the biotin-labelled
DNA:mRNA:miRNA complexes and the Dynabeads did
not dissociate the mRNA:miRNA interactions, AAT
mRNA qRT-PCR and miR-940 Taqman assays were
carried out on the magnetic beads pre-80C heat treatment
and on the eluted samples post-80C heat treatment
(Figure 3C). There were negligible levels of AAT mRNA
and miR-940 in these samples, indicating that the mRNA
and miRNAs are not lost at this step in the procedure.
These samples were also compared with samples (artiﬁ-
cially set to 1.0) that were subsequently treated with pro-
teinase K at 42C for 1 h followed by 65C heat treatment
for 20min to reverse the formaldehyde cross-links and
release the mRNA and miRNAs, wherein 30–50-fold
higher levels of AAT mRNA and 22–33-fold higher
levels of miR-940 were present. Thus, the 5-min heat treat-
ment at 80C is optional.
Additional capture oligonucleotides against AAT
mRNA were also tested. The ﬁrst capture oligonucleotide
(set to 1.0) was far superior in capturing AAT mRNA
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compared with capture oligonucleotides targeting a
second predicted exposed single-stranded loop, an
equimolar combination of capture oligonucleotides
directed at loop 1 and loop 2 or a capture oligonucleotide
targeting a predicted double-stranded sequence
(Figure 3D). A capture oligonucleotide with three
mismatches directed against the ﬁrst loop was also used,
but there was no enrichment of any mRNA including
AAT mRNA (data not shown).
SLPI mRNA- and IL-8 mRNA-speciﬁc isolation
To determine whether this mRNA:miRNA complex
afﬁnity puriﬁcation method was applicable to other
mRNAs, strategies to isolate SLPI and IL-8 mRNAs
were devised. SLPI has one transcript variant of 598
bases; IL-8 has one transcript variant of 1718 bases.
Although the most thermodynamically stable secondary
structure of SLPI mRNA revealed a 30-nucleotide loop
at position 546–576, IL-8 mRNA did not have any pre-
dicted single-stranded loop >15 nucleotides (Figure 4);
instead, a capture oligonucleotide directed against a pre-
dicted double-stranded region was designed. In THP-1
cells, capture using SLPI mRNA-speciﬁc oligonucleotide
showed enrichment for SLPI mRNA, whereas IL-8
mRNA could be enriched using an IL-8 mRNA-speciﬁc
capture oligonucleotide in cells stimulated with LPS (both
of these values set to 1.0). Importantly, these mRNAs
were not enriched when mismatch capture oligonucleo-
tides (with three nucleotide changes compared to the
wild-type sequence) were used. miR-19a (set to 1.0) and
miR-19b are predicted in silico to target SLPI mRNA and
were detected in the captured samples, whereas let-7b (set
to 1.0) and miR-23b, which are predicted to target IL-8
mRNA, were also detectable in the IL-8 mRNA captured
assays.
miRNA expression proﬁling and testing AAT mRNA- and
cell-speciﬁc miRNAs
In the AAT mRNA captured samples, miRNA Taqman
assays were performed to conﬁrm the enrichment of
miR-940, miR-132 and miR-212, but not miR-16 or
miR-19a, miRNAs that are not predicted to regulate
AAT mRNA (Figure 5A). None of these miRNAs were
detected in samples when the mismatch capture oligo-
nucleotide was used to capture AAT mRNA (data not
shown). Proﬁling three pooled samples of total or AAT
mRNA-speciﬁc miRNA from THP-1, 16HBE14o and
HepG2 cells to examine the expression of 731 different
Figure 2. Strategy for single (AAT) mRNA:miRNA afﬁnity puriﬁcation. (1) Cells are treated with formaldehyde to cross-link miR-Ago-RISC
complexes with mRNA. (2) Cells are lysed, treated with RNase-free DNase and the biotinylated DNA oligonucleotide is used to capture only
AAT mRNA:miRNA complexes with streptavidin-coated magnetic beads. (3) Samples are eluted from the magnetic beads, the DNase is inactivated
and the formaldehyde cross-linking is reversed. Samples can be used for qRT-PCR and miRNA expression proﬁling.
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human miRNAs was performed using NanoString
Technologies miRNA Expression Kit. Appreciable target
detection (normalized data after probe and background
correction >1) occurred for 196 miRNAs across all
three cell lines (97 in all cell lines; 8, 25 and 19 exclusively
in THP-1, 16HBE14o and HepG2, respectively; 20, 9
and 18 in two of the cell lines) (Supplementary Figure
S7). miR-940, which regulates AAT mRNA and protein
expression (Supplementary Figures S3–6), was not repre-
sented in this miRNA expression kit.
When AAT mRNA-speciﬁc miRNAs were proﬁled, 42,
15, 5 and 30 AAT mRNA-speciﬁc miRNAs were detected
in all three cell lines, THP-1, 16HBE14o and HepG2
cells, respectively (Figure 5B and Supplementary Figure
S8). By correlating appreciable target detection of AAT
mRNA-speciﬁc miRNAs with miRNA abundance, miR-
SVR score, the number of MREs predicted in the AAT
mRNA 30UTR by miRanda and the number of MREs
predicted for the whole length of the AAT mRNA pre-
dicted by PITA, we observed correlations between
captured AAT mRNA-speciﬁc miRNAs and miR-SVR
scores and the number of predicted MREs
(Supplementary Figure S9). These miRNAs were cross-
referenced with the target prediction databases
miRanda, TargetScan and PITA to identify 30UTR and
non-30UTR miRNAs. Of the miRNAs captured, 63%
were predicted to target the 30UTR and non-30UTR of
transcript variant 1.
Next, we cross-referenced 30UTR sequences predicted in
silico with our proﬁling data to narrow down the miRNAs
selected for functional studies. Four miRNAs with good
miR-SVR scores, which were both cell and AAT
mRNA-speciﬁc, were selected including miR-455-3p
expressed in all cell lines, miR-328, miR-769-5p
and miR-296-5p expressed exclusively in THP-1,
16HBE14o and HepG2, respectively. Co-transfection
with these pre-miRs resulted in signiﬁcant decreases in
luciferase gene expression from the reporter vector con-
taining the AAT 30UTR of 15–53% (Figure 5C) when
compared with non-transfected and negative control pre-
miR-transfected cells, demonstrating a causal relationship
between the miRNAs isolated from AAT mRNA:miRNA
complexes and the AAT 30UTR.
Functional effects of AAT mRNA-speciﬁc pre-miRs
To determine whether the AAT mRNA-speciﬁc miRNAs
have cell-speciﬁc effects on AAT expression, the selected
miRNAs were overexpressed in three cell lines using pre-
miR transfection. miR-455-3p is expressed in all three
cell lines. Overexpression of pre-miR-455-3p led to
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Figure 3. Validation of AAT mRNA-speciﬁc isolation technique. (A) qRT-PCR showing the enrichment of AAT mRNA compared with other
mRNAs. Expression of captured mRNA was normalized to baseline expression of these transcripts in HepG2 cell lysates to demonstrate enrichment
of the AAT mRNA compared with other highly abundant mRNAs. (B) qRT-PCR comparing the level of AAT mRNA and other mRNAs in
captured samples compared with levels in the remaining cell lysates after capture. (C) AAT mRNA and miR-940 levels detectable on dynabeads
pre-80C heat treatment (sample 1), in eluates post-80C heat treatment (sample 2) and in samples after reversal of formaldehyde cross-linking
(sample 3). (D) Additional targets to capture AAT mRNA including a second predicted loop (2nd loop) from position 2454–2572 and a
double-stranded sequence (non-loop) from position 2533–2554. Relative expression of AAT mRNA following capture with the capture oligonucleo-
tides as indicated. Relative mRNA and miRNA expression were quantiﬁed using the 2Ct method. Assays were performed in triplicate (n=3).
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small but signiﬁcant decreases for both AAT mRNA and
protein expression in THP-1, 16HBE14o and HepG2
cells of 12–42% and 10–35%, respectively (Figure 6,
where ‘no pre-miR’ was normalized to 1.0) and
had greater effects in HepG2s at higher concentrations
(Supplementary Figure S10). miR-328 targets AAT
mRNA and is expressed uniquely in THP-1
cells. miR-328 overexpression resulted in small yet signiﬁ-
cant reductions of AAT mRNA and protein in THP-1
cells only. Similar results were also seen with miR-
769-5p in 16HBE14o cells and miR-296-5p in HepG2
cells.
Transfections were also performed with pre-miR-19b
and -218. miR-19b was detected in AAT mRNA-speciﬁc
and total miRNAs in all three cell lines but was not pre-
dicted to target AAT mRNA in TargetScan, miRanda or
PITA. Meanwhile, miR-218 was strongly predicted in the
latter databases, expressed in all three cell lines but not
detected as an AAT mRNA-speciﬁc miRNA in any of the
cell lines. Interestingly, pre-miR-19b transfection signiﬁ-
cantly decreased the expression of AAT mRNA in
THP-1 (which was artiﬁcially set to 1.0) and HepG2
cells and decreased protein expression in THP-1s. Pre-
miR-218 had little effect on AAT mRNA or protein ex-
pression and only signiﬁcantly decreased AAT mRNA in
THP-1s (Figure 7).
DISCUSSION
Here, we present a novel method to identify multiple
miRNAs targeting a known mRNA. This approach was
used to isolate AAT, IL-8 and SLPI mRNAs with their
miRNAs bound to RISC via formaldehyde cross-linking.
Once captured using a biotinylated antisense oligonucleo-
tide and magnetic beads, the cross-links in these
complexes were reversed, and the RNA species were
analysed with qRT-PCR and Taqman assay. In the case
of AAT mRNA, its co-captured miRNAs were proﬁled,
and the data showed that cell-speciﬁc miRNAs differen-
tially regulate AAT expression in three cell types; THP-1,
16HBE14o and HepG2.
Owing to imperfect seeding of the mRNA:miRNA
interaction, a method that bypasses or complements
bioinformatic predictions can have several advantages.
This method is an experimental approach for
high-throughput identiﬁcation of miRNAs targeting a
speciﬁc mRNA. The false-positive rate of prediction
programs has been reported to be 24–70% (5), and
each program uses unique rules of targeting that can
generate different lists of predicted targets. Combining
the results of a variety of computational programs does
increase the speciﬁcity of miRNA target identiﬁcation.
Here, we describe an experimental approach to generate
a similar result and suggest that this method is a
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Figure 4. mRNA:miRNA isolation technique for (A) SLPI mRNA and (B) IL-8 mRNA from THP-1 cells. In all, 30-mer probes were designed to
capture (i) a predicted single-stranded loop present in the SLPI mRNA and a predicted double-stranded sequence in the IL-8 mRNA (capture
performed in three independent samples). qRT-PCR showed enrichment of (ii) SLPI and IL-8 mRNAs where expression of each transcript was
normalized to the respective baseline expression in cell lysates using the 2Ct method. Taqman assays showed enrichment of (iii), miR-19a/
miR-19b and let-7b/miR-23b, but not of miR-16 in samples captured with transcript-speciﬁc capture or mismatch oligonucleotides. mRNA and
miRNA expression were quantiﬁed using the 2Ct method.
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complementary tool for researchers studying miRNA
regulation of target mRNAs. For example, in this study,
cross-referencing of the captured miRNAs with those pre-
dicted to bind to the 30UTR resulted in a highly selective
and smaller number of miRNAs, presumably eliminating
false positives for 30UTR-related miRNAs.
Most miRNA target prediction methods are limited to
30UTR sites. Given that the full-length transcript is used
to capture interacting miRNAs, this method can also po-
tentially identify miRNAs binding to coding and 50UTR
regions of a transcript and is an advantage over other
afﬁnity puriﬁcation systems, which identify miRNAs
that target the 30UTR of an mRNA (16). Recent studies
have shown that miRNA-mediated regulation is not
limited to the 30UTR, although the functionality of
target sites in the 50UTR and coding region requires
further investigation. Comparable with the HITS-CLIP
data, the PAR-CLIP study revealed that although 46%
of miRNA-binding sites were mapped to the 30UTR, the
other 50 and 4% of miRNAs were bound to the coding
region and 50UTR, respectively. We have not, as yet, per-
formed studies to validate the effects of these potential
coding region- and 50UTR-targetting miRNAs with
respect to regulation of the AAT mRNA.
The method described here can be easily applied to a
variety of mRNAs as shown in this study for three
separate target mRNAs. Initially, an important aspect of
the miRNA:mRNA capturing technique was designing the
anti-sense capture oligonucleotide. Modelling the second-
ary RNA structure of all AAT transcript variants with the
M-fold web server identiﬁed a single-stranded region,
which is present in the most thermodynamically stable
structure of all variants; this region was used to design a
capture oligonucleotide. However, the energetic model
that M-fold uses ignores 3-dimensional interactions or
protein–RNA interactions that could stabilize or desta-
bilize an RNA fold. In addition, predictions from
M-fold may not always correspond to the true biological
fold of the RNA. Therefore, although the secondary struc-
ture predicted by M-fold is unlikely to be identical to the
folding structure of mRNA complexed to miRNAs, we
have performed a number of experiments to suggest that
in the AAT and SLPI mRNAs, a capture oligonucleotide
that targets a predicted single-stranded loop is efﬁcient.
For SLPI mRNA, a 30-mer oligonucleotide based on
this principle was effective. For AAT mRNA, two oligo-
nucleotides designed to capture 22 and 20 base predicted
single-stranded loops available in 22 secondary RNA
structures representing the two most thermodynamically
stable predictions for each of the 11 variants successfully
captured AAT mRNA. Interestingly, when these two
loops were used as combined capture oligonucleotides,
the capture efﬁciency was reduced. This differs from
another method that uses dozens of short oligonucleotide
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Figure 5. miRNA expression proﬁling and testing of AAT mRNA- and cell-speciﬁc miRNAs. (A) Relative miRNA expression in AAT mRNA
captured samples was quantiﬁed using the 2Ct method. Assays were performed in triplicate (n=3). (B) Numbers of miRNAs interacting with
AAT mRNA in THP-1, 16HBE14o and HepG2 cells using NanoString Technologies miRNA Expression Kit. (C) Relative luciferase activity was
measured in HEK293 cells (1 105 in triplicate) transiently transfected with pMIR-AAT-30UTR and pRLSV40 and co-transfected with synthetic
pre-miRs as indicated. Fireﬂy luciferase activity was normalized to the Renilla luciferase activity. Data are represented as mean±SEM and were
compared by t-test for negative control pre-miR versus pre-miR; data are representative of three experiments.
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probes to tile the length of a long non-coding RNA and
requires no prior knowledge of an RNA’s secondary struc-
ture or functional domains (24). Conversely, we have also
shown that capture oligonucleotides designed against pre-
dicted double-stranded sequences can also successfully
capture AAT or IL-8 mRNAs. However, the efﬁciency
of the IL-8 capture oligonucleotide cannot be compared
with one that targets a predicted loop, as the secondary
structure did not reveal any loop of >15 bases. Overall,
although designing capture oligonucleotides based on pre-
dicted single-stranded regions within the secondary struc-
ture of target mRNAs was effective, given that this may
not be the conformation adopted in vivo, any capture
oligonucleotide based on a 20-mer sequence within the
target mRNA should be effective, provided it is exclusive
to that mRNA.
This method can be used to detect and compare
miRNAs bound to a particular mRNA under different
conditions, for example diseased versus healthy or
treated versus non-treated, thus capturing the dynamic
changes of miRNA:mRNA interactions in a biological
system. Here, it was used to demonstrate cell-speciﬁc regu-
lation of AAT mRNA by different miRNAs in three
unrelated cell types. By selecting miRNAs with a good
miR-SVR score and multiple MREs in the 30UTR of the
AAT mRNA, we attempted to select miRNAs that
strongly regulate the AAT mRNA and conﬁrmed this by
showing AAT mRNA and protein downregulation follow-
ing speciﬁc miRNA overexpression, in a cell-speciﬁc
manner. In another example, the IL-8 mRNA-speciﬁc
miRNAs captured after treatment of monocytic cells
with lipopolysaccharide likely reﬂects miRNAs speciﬁc
to this biological event. However, by pooling samples
for the miRNA proﬁling, we cannot comment on the re-
producibility and inherent variability of the genome-wide
aspect of the method. Therefore, the proﬁling data pre-
sented here represents a preliminary approach to select
miRNAs for subsequent qRT-PCR work.
Another unique feature of this method compared with
other technologies is the fact that the full-length endogen-
ous mRNA is isolated, presumably in its natural conform-
ation bound to innate miRNAs and Argonuate proteins,
thereby reﬂecting the natural biological process in differ-
ent cell types. Although other methods such as PAR-CLIP
also have the advantage of analysing RNA–protein inter-
actions in their native architecture, ultraviolet as opposed
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Figure 6. Effects of pre-miR-455-3p, pre-miR-328, pre-miR-769-5p and pre-miR-296-5p overexpression on AAT mRNA (top) and protein (below)
expression in (A) THP-1, (B) 16HBE14o and (C) HepG2. Cells (1 105 in triplicate) were left untreated (no pre-miR) or transfected with 30 nM
negative control pre-miR (control pre-miR) or synthetic pre-miRs as indicated. 24 h post-transfection RNA was isolated and used in qRT-PCR
reactions with AAT and GAPDH primers. Relative AAT mRNA expression was quantiﬁed using the 2Ct method. Thereafter, 24 and 48 h culture
supernatants were pooled and assayed by ELISA to quantify AAT protein expression. Assays were performed in triplicate (n=3). Data were
compared by t-test for negative control pre-miR versus pre-miRs. Note, miR-455-3p was detected in all AAT mRNA-speciﬁc miRNAs assays,
whereas miR-328, miR-769-5p and miR-296-5p were detected in THP-1, 16HBE14o and HepG2 cells, respectively.
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to formaldehyde cross-linking can cause some redistribu-
tion of cellular components and lead to ultraviolet-
damaged molecules. Formaldehyde cross-linking has the
advantage of being reversible and has been used in the
identiﬁcation of RISC proteins that bind to mRNAs and
of miRNAs that bind to target mRNAs (25).
Formaldehyde is also used in RNA–protein chromatin
immunoprecipitation, which cross-links RNA–protein
complexes in living cells and isolates these by immunopre-
cipitation using a speciﬁc antibody (26). Similar to RNA–
protein chromatin immunoprecipitation in which the
results obtained are highly dependent on the quality of
the immunoprecipitating antibody, the key to successful
capturing using this method depends on the quality of the
DNA anti-sense oligonucleotide.
Unlike PAR-CLIP and HITS-CLIP, this system does
not map interaction sites. In addition, it is not possible
to assess or predict the impact of the captured miRNAs on
regulation of the target mRNA without further experi-
mental validation. Thus, although initial bioinformatic
screening is not necessary, these programs are important
tools in subsequent analysis to predict MREs. Although
some non-target mRNAs were detectable in the captured
samples, possibly owing to their high abundance and/or
ability to bind non-speciﬁcally to the oligo-beads, the
normalized enrichment ratios were small. Interestingly,
by using the nCounter miRNA expression assay, which
does not use reverse transcription or pre-ampliﬁcation,
real-time quantiﬁcation of bound miRNAs reﬂects a
high likelihood of AAT mRNA-speciﬁc miRNAs, with
miRNA abundance likely depending on the presence of
multiple binding sites in the target. Unlike other miRNA
microarrays or qRT-PCR, this assay is more appropriate
for methods that are unbiased but likely to have minimal
contamination from non-speciﬁc miRNAs.
Three interesting observations were noted here regard-
ing AAT mRNA and its co-captured miRNAs: (i) some
miRNAs that were predicted in silico, which had an effect
on the AAT 30UTR reporter gene, and that were
co-captured with AAT mRNA did not have a functional
effect on AAT mRNA or protein expression when tested
in pre-miR and anti-miR experiments (i.e. miR-32 and
miR-212). This suggests that although the speciﬁc associ-
ation of some miRNAs with a particular mRNA can be
demonstrated, the interaction on occasion may show no
functional effect. It is not known why this is the case, and
it may be owing to, as yet undetermined, miRNA- or
transcript-speciﬁc inhibitory factors. The percentage
miRNA knockdown by anti-miRs in this case was small;
therefore, further experiments using higher concentrations
of anti-miRs may help to explain this phenomenon. (ii)
miR-218 was strongly predicted to target AAT mRNA
and although detectable in the total miRNA proﬁle of
the three cell types was not isolated with AAT mRNA
and did not have a signiﬁcant effect on AAT mRNA or
protein expression other than in THP-1 cells. However, as
the activity of a miRNA in a particular cell type is a
function of its availability and the demand for its
binding, ‘target competition’ could explain in part why
predicted and expressed miRNAs such as miR-218 are
absent from the pull-down. Further validation should
include wild-type and mutant AAT 30UTR reporter
assays carried out in the actual cell line of interest to
allow for competition with, for example endogenous
RBPs and other miRNAs that might be confounding
factors. Mimic and antagonist dose–response experiments
would also be required to validate whether miR-218 can
truly regulate AAT mRNA. Importantly, although mimic
overexpression studies demonstrate that a miRNA can
regulate a target mRNA when present in vast stoichiomet-
ric excess, anti-miRs show whether these miRNA do
regulate the mRNA by disrupting endogenous complexes.
(iii) miR-19b was not predicted to regulate AAT mRNA
but was captured with AAT mRNA and had inhibitory
effects on AAT mRNA and protein expression in some
pre-miR experiments. For miR-19b and all miRNAs
isolated by this method, it is recommended that additional
biochemical assays be performed to independently conﬁrm
the observations. This should be standard practice when
conﬁrming data generated using any afﬁnity capture
method and is particularly important, given that
miRNA targets can differ temporally and spatially.
Furthermore, miRNAs regulate target mRNA expression
in a moderate way and can work synergistically or
additively with other miRNAs. Overall, the results pre-
sented here suggest that the combined regulation of
many different factors determines the cell- and
target-speciﬁc functionality of a miRNA.
This study provides direct evidence of miRNAs target-
ing and modulating AAT mRNA and protein expression.
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Figure 7. The effects of pre-miR-19b and pre-miR-218 overexpression
on (A) AAT mRNA and (B) AAT protein expression in THP-1,
16HBE14o and HepG2. Cells (1 105 in triplicate) were transfected
with 30 nM negative control pre-miR (control pre-miR) or synthetic
pre-miRs as indicated. Twenty-four hours post-transfection RNA was
isolated and used in qRT-PCR reactions with AAT and GAPDH
primers. Relative AAT mRNA expression for each cell type was
quantiﬁed using the 2Ct method. Thereafter, 24 and 48 h culture
supernatants were assayed by ELISA to quantify AAT protein expres-
sion. Data presented in y-logarithmic axis for B. Assays were per-
formed in triplicate (n=3). Data were compared by t-test for
negative control pre-miR versus pre-miRs.
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Expression levels of AAT are known to vary in different
cell types and in response to different stimuli (27).
Previous studies have focused on cell and stimulus-speciﬁc
transcriptional regulation with a tissue-speciﬁc promoter
known to be present in the liver. The transcription factors
hepatocyte nuclear factor 1-alpha and 4 regulate basal
AAT mRNA expression however, as an acute-phase
response protein, an enhancer sequence modulates
cytokine-induced expression by interleukin-6 and
oncostatin M (28). Alternative promoters have also been
shown for other tissues that express AAT (29,30). Here,
we show that cell-speciﬁc miRNA expression is likely to be
another previously unrecognized mechanism modulating
cell-speciﬁc AAT expression. However, it is important to
acknowledge that given that the expression of AAT
mRNA ranges 10-fold whilst the protein ranges over
1000-fold between different cell types, secondary mechan-
isms other than miRNA, such as cell-speciﬁc mRNA
stability and translation efﬁciency are also likely at play.
In conclusion, this is a simple and efﬁcient method of
identifying native interacting miRNAs targeting the whole
sequence of an endogenous mRNA transcript. Together
with target prediction programs and more sensitive and
speciﬁc assays for further elucidation of miRNA biogen-
esis and functionality, this method is likely to signiﬁcantly
advance miRNA research.
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